Balchem (BCPC) Financials

$161.75 +0.55 (+0.34%)

Closing price 04:00 PM Eastern

Extended Trading

$161.70 -0.05 (-0.03%)

As of 04:10 PM Eastern

Annual Income Statements for Balchem

This table shows Balchem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	60	56	90	79	80	85	96	105	109	128	155
Consolidated Net Income / (Loss)	60	56	90	79	80	85	96	105	109	128	155
Net Income / (Loss) Continuing Operations	60	56	90	79	80	85	96	105	109	128	155
Total Pre-Tax Income	87	83	88	99	96	106	125	134	137	166	199
Total Operating Income	94	91	97	107	103	111	128	145	159	183	209
Total Gross Profit	168	181	189	204	211	224	243	280	302	336	371
Total Revenue	552	553	595	644	644	704	799	942	922	954	1,037
Operating Revenue	552	553	595	644	644	704	799	942	922	954	1,037
Total Cost of Revenue	384	372	406	439	432	480	556	662	620	617	667
Operating Cost of Revenue	384	372	406	439	432	480	556	662	620	617	667
Total Operating Expenses	74	90	92	97	109	113	116	135	143	153	161
Selling, General & Admin Expense	68	83	83	86	97	102	102	123	128	137	143
Research & Development Expense	5.99	7.33	9.31	12	11	10	14	12	15	17	19
Total Other Income / (Expense), net	-6.89	-7.90	-8.42	-8.07	-6.08	-4.73	-2.27	-11	-22	-16	-10
Interest & Investment Income	0.01	-	-	-	-	-	-	-10	-23	-17	-10
Other Income / (Expense), net	-0.31	-0.65	-0.88	-0.46	-0.12	-0.29	0.19	-1.17	0.68	0.07	-0.08
Income Tax Expense	27	27	-1.58	20	17	22	29	28	29	38	44
Basic Earnings per Share	$1.92	$1.78	$2.83	$2.45	$2.48	$2.63	$2.98	$3.29	$3.38	$3.97	$4.80
Weighted Average Basic Shares Outstanding	31.16M	31.52M	31.84M	32.09M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M	32.03M
Diluted Earnings per Share	$1.89	$1.75	$2.79	$2.42	$2.45	$2.60	$2.94	$3.25	$3.35	$3.93	$4.75
Weighted Average Diluted Shares Outstanding	31.16M	31.52M	31.84M	32.09M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M	32.03M
Weighted Average Basic & Diluted Shares Outstanding	31.16M	31.52M	31.84M	32.09M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M	32.03M
Cash Dividends to Common per Share	-	-	-	-	-	-	-	$0.71	$0.79	$0.87	$0.96

This table shows Balchem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	29	27	29	32	34	34	37	38	40	39	40
Consolidated Net Income / (Loss)	29	27	29	32	34	34	37	38	40	39	40
Net Income / (Loss) Continuing Operations	29	27	29	32	34	34	37	38	40	39	40
Total Pre-Tax Income	36	33	37	41	44	44	48	49	52	50	53
Total Operating Income	44	38	42	46	48	47	51	51	55	52	56
Total Gross Profit	77	75	82	83	85	86	88	93	95	94	101
Total Revenue	230	229	240	234	240	240	251	255	268	264	271
Operating Revenue	230	229	240	234	240	240	251	255	268	264	271
Total Cost of Revenue	153	154	158	151	155	154	162	162	172	170	170
Operating Cost of Revenue	153	154	158	151	155	154	162	162	172	170	170
Total Operating Expenses	33	37	40	37	37	39	37	42	41	42	45
Selling, General & Admin Expense	29	33	36	33	33	34	32	37	36	37	40
Research & Development Expense	3.87	3.94	4.10	3.85	4.33	4.51	4.66	4.30	4.50	5.05	5.88
Total Other Income / (Expense), net	-7.14	-5.07	-4.83	-4.57	-4.10	-2.96	-3.08	-2.43	-2.54	-2.26	-3.10
Interest & Investment Income	-6.59	-	-5.40	-4.24	-4.07	-	-2.92	-2.77	-2.63	-1.90	-2.21
Other Income / (Expense), net	-0.55	0.22	0.57	-0.33	-0.03	-0.14	-0.15	0.34	0.09	-0.36	-0.89
Income Tax Expense	7.40	6.62	7.86	9.16	10	11	11	11	12	11	12
Basic Earnings per Share	$0.91	$0.82	$0.90	$0.99	$1.05	$1.03	$1.14	$1.18	$1.25	$1.23	$1.26
Weighted Average Basic Shares Outstanding	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M	32.62M	32.46M	32.39M	32.03M	32.13M
Diluted Earnings per Share	$0.90	$0.82	$0.89	$0.98	$1.03	$1.03	$1.13	$1.17	$1.24	$1.21	$1.25
Weighted Average Diluted Shares Outstanding	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M	32.62M	32.46M	32.39M	32.03M	32.13M
Weighted Average Basic & Diluted Shares Outstanding	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M	32.62M	32.46M	32.39M	32.03M	32.13M

This table details how cash moves in and out of Balchem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	35	-46	1.77	14	11	19	19	-37	-2.11	-15	25
Net Cash From Operating Activities	104	108	111	119	124	150	161	139	184	182	217
Net Cash From Continuing Operating Activities	104	108	111	119	124	150	161	139	184	182	217
Net Income / (Loss) Continuing Operations	60	56	90	79	80	85	96	105	109	128	155
Consolidated Net Income / (Loss)	60	56	90	79	80	85	96	105	109	128	155
Depreciation Expense	40	46	44	45	46	51	49	52	55	48	46
Non-Cash Adjustments To Reconcile Net Income	4.25	7.59	6.93	4.87	7.45	11	11	15	12	19	17
Changes in Operating Assets and Liabilities, net	-0.11	-2.15	-31	-9.41	-8.52	3.91	4.99	-34	8.71	-13	-1.20
Net Cash From Investing Activities	-42	-134	-43	-32	-156	-35	-35	-416	-35	-60	-44
Net Cash From Continuing Investing Activities	-42	-134	-43	-32	-156	-35	-35	-416	-35	-60	-44
Purchase of Property, Plant & Equipment	-41	-23	-28	-20	-28	-34	-37	-50	-38	-36	-43
Acquisitions	-1.01	-112	-17	-17	-141	0.00	0.00	-366	-1.25	-24	-0.32
Purchase of Investments	-	-	0.00	0.00	-1.00	-0.85	-0.09	-0.50	-0.29	-0.27	-0.35
Sale of Property, Plant & Equipment	0.03	0.00	0.02	0.97	12	0.09	0.32	0.21	1.88	0.36	0.27
Sale and/or Maturity of Investments	0.00	-	-	-	-	-	0.00	0.00	2.74	0.00	0.00
Net Cash From Financing Activities	-26	-19	-69	-71	43	-101	-102	247	-153	-134	-153
Net Cash From Continuing Financing Activities	-26	-19	-69	-71	43	-101	-102	247	-153	-134	-153
Repayment of Debt	-35	-89	-89	-276	-94	-95	-60	-135	-149	-146	-114
Repurchase of Common Equity	-1.21	-1.59	-1.91	-1.39	-21	-13	-35	-35	-4.47	-5.68	-108
Payment of Dividends	-9.25	-11	-12	-13	-15	-17	-19	-21	-23	-26	-28
Issuance of Debt	-	73	25	211	169	10	5.00	435	18	26	88
Other Financing Activities, net	20	9.74	9.73	8.27	4.84	14	6.78	3.04	5.02	17	9.11
Effect of Exchange Rate Changes	-1.20	-0.72	2.48	-1.41	-0.22	4.16	-4.37	-5.88	2.26	-3.38	5.20

This table details how cash moves in and out of Balchem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	10	-13	-4.10	3.39	9.96	-24	0.39	16	-0.33	9.48	-1.70
Net Cash From Operating Activities	47	67	33	45	51	52	36	47	66	67	40
Net Cash From Continuing Operating Activities	47	67	33	45	51	52	36	47	66	67	40
Net Income / (Loss) Continuing Operations	29	27	29	32	34	34	37	38	40	39	40
Consolidated Net Income / (Loss)	29	27	29	32	34	34	37	38	40	39	40
Depreciation Expense	14	14	14	13	11	11	11	11	12	12	12
Non-Cash Adjustments To Reconcile Net Income	5.50	4.04	4.10	4.63	5.04	4.76	3.82	4.90	4.30	4.34	6.51
Changes in Operating Assets and Liabilities, net	-1.86	23	-13	-4.22	1.53	3.07	-15	-7.30	9.43	12	-19
Net Cash From Investing Activities	-9.28	-12	-6.74	-6.86	-9.18	-37	-5.91	-6.62	-15	-16	-6.29
Net Cash From Continuing Investing Activities	-9.28	-12	-6.74	-6.86	-9.18	-37	-5.91	-6.62	-15	-16	-6.29
Purchase of Property, Plant & Equipment	-8.30	-12	-6.91	-6.88	-9.15	-13	-5.56	-6.81	-15	-16	-6.25
Acquisitions	-0.91	-	0.00	-	-	-24	-0.32	-	-	-	0.00
Purchase of Investments	-0.07	-0.15	-0.04	-0.04	-0.03	-0.16	-0.03	-0.08	-0.04	-0.21	-0.04
Sale of Property, Plant & Equipment	-	-	0.21	-	-	-	0.00	0.27	-	0.01	0.00
Net Cash From Financing Activities	-25	-70	-30	-34	-34	-35	-32	-29	-51	-41	-35
Net Cash From Continuing Financing Activities	-25	-70	-30	-34	-34	-35	-32	-29	-51	-41	-35
Repayment of Debt	-30	-71	-34	-35	-40	-37	-29	-34	-43	-8.00	-47
Repurchase of Common Equity	-0.10	-0.44	-5.20	-0.01	-0.16	-0.31	-5.33	-33	-15	-54	-16
Payment of Dividends	-0.00	-	-26	-0.01	-0.00	-0.00	-28	-0.00	-0.01	-0.01	-31
Issuance of Debt	5.00	-	26	-	-	-	29	34	7.00	18	52
Other Financing Activities, net	0.01	1.30	8.73	0.84	5.34	2.10	1.62	4.51	0.60	2.39	6.68
Effect of Exchange Rate Changes	-2.06	2.10	-0.72	-0.56	2.23	-4.32	1.81	3.66	-0.13	-0.13	-0.68

This table presents Balchem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	880	949	964	981	1,156	1,166	1,199	1,625	1,597	1,575	1,686
Total Current Assets	198	188	199	226	255	267	322	336	314	314	366
Cash & Equivalents	85	39	40	54	66	85	103	67	64	50	75
Accounts Receivable	60	83	91	100	93	98	117	132	125	120	144
Inventories, net	46	57	61	67	84	71	91	120	110	131	131
Prepaid Expenses	3.21	4.11	4.77	3.83	4.39	6.60	6.12	4.90	7.80	8.05	9.78
Other Current Assets	2.91	4.48	2.22	1.48	2.45	3.44	4.41	13	7.19	5.74	6.22
Plant, Property, & Equipment, net	159	166	190	191	217	228	238	271	276	282	307
Total Noncurrent Assets	523	594	575	564	684	671	640	1,017	1,007	979	1,014
Noncurrent Note & Lease Receivables	-	-	-	-	-	2.57	2.36	2.34	2.10	1.73	1.52
Goodwill	384	440	441	448	524	529	524	770	779	780	816
Intangible Assets	135	147	128	109	144	122	95	213	191	165	163
Other Noncurrent Operating Assets	4.06	7.14	5.07	6.72	16	17	19	32	35	33	33
Total Liabilities & Shareholders' Equity	880	949	964	981	1,156	1,166	1,199	1,625	1,597	1,575	1,686
Total Liabilities	416	428	347	290	412	338	322	686	543	425	429
Total Current Liabilities	81	101	108	82	92	94	144	140	148	158	176
Accounts Payable	15	33	28	33	37	24	56	57	56	55	60
Accrued Expenses	13	15	23	22	25	30	43	37	41	44	49
Dividends Payable	11	12	13	15	17	19	21	23	26	29	31
Current Deferred & Payable Income Tax Liabilities	2.73	-	-	0.44	-	0.00	1.33	2.28	4.97	4.47	3.91
Current Employee Benefit Liabilities	5.13	6.65	8.53	11	11	20	20	17	17	23	28
Other Current Liabilities	-	-	-	-	2.48	2.34	2.36	4.02	4.22	3.33	3.82
Total Noncurrent Liabilities	335	327	238	208	320	243	179	546	395	268	252
Long-Term Debt	268	252	190	163	256	174	109	467	326	209	185
Capital Lease Obligations	-	-	-	0.00	-	2.47	2.30	2.21	1.94	1.75	1.54
Noncurrent Deferred & Payable Income Tax Liabilities	67	74	49	44	56	51	46	63	52	44	54
Other Noncurrent Operating Liabilities	-	-	-	0.00	6.93	15	21	14	15	13	11
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	464	521	617	692	744	828	877	938	1,054	1,150	1,257
Total Preferred & Common Equity	464	521	617	692	744	828	877	938	1,054	1,150	1,257
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	464	521	617	692	744	828	877	938	1,054	1,150	1,257
Common Stock	125	140	154	167	176	167	150	131	148	176	94
Retained Earnings	344	388	465	528	591	657	732	814	897	997	1,121
Accumulated Other Comprehensive Income / (Loss)	-5.11	-6.85	-1.64	-3.60	-5.56	4.17	-4.99	-7.15	8.69	-24	42

This table presents Balchem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,633	1,629	1,619	1,603	1,589	1,575	1,597	1,618	1,678	1,661	1,694
Total Current Assets	368	336	337	341	325	320	326	340	365	344	389
Cash & Equivalents	56	60	67	77	60	64	74	50	65	65	73
Accounts Receivable	141	131	125	129	140	123	121	130	136	132	154
Inventories, net	139	125	125	116	110	117	119	145	148	132	147
Prepaid Expenses	6.94	7.43	8.83	7.24	7.12	9.96	7.83	8.13	9.49	8.90	8.96
Other Current Assets	20	12	7.24	6.59	7.13	5.96	5.42	6.83	5.81	5.74	6.14
Plant, Property, & Equipment, net	260	276	271	269	274	273	277	284	290	298	303
Total Noncurrent Assets	1,005	1,017	1,011	993	990	982	994	994	1,023	1,019	1,002
Noncurrent Note & Lease Receivables	2.20	2.28	2.22	2.16	2.04	1.98	1.78	1.68	1.63	1.57	1.47
Goodwill	749	774	774	767	772	770	781	793	816	816	811
Intangible Assets	227	209	203	192	182	176	178	166	172	167	156
Other Noncurrent Operating Assets	26	31	32	33	34	34	33	33	33	34	32
Total Liabilities & Shareholders' Equity	1,633	1,629	1,619	1,603	1,589	1,575	1,597	1,618	1,678	1,661	1,694
Total Liabilities	737	655	612	578	510	463	420	409	410	363	409
Total Current Liabilities	142	117	114	108	124	113	109	140	138	126	153
Accounts Payable	73	53	56	50	60	55	46	66	68	47	71
Accrued Expenses	50	43	41	43	38	37	40	44	48	49	52
Dividends Payable	0.13	0.19	0.19	0.18	0.07	0.05	0.05	0.13	0.12	0.11	0.17
Current Deferred & Payable Income Tax Liabilities	0.00	7.88	0.00	0.00	12	3.44	1.96	14	0.57	6.45	13
Current Employee Benefit Liabilities	15	9.22	13	12	11	15	18	12	18	20	13
Other Current Liabilities	3.90	3.06	4.09	3.86	4.05	3.84	3.40	3.92	3.87	4.15	3.65
Total Noncurrent Liabilities	595	539	498	470	385	349	310	269	272	237	256
Long-Term Debt	477	461	421	396	319	284	245	210	211	175	191
Capital Lease Obligations	2.17	2.16	2.10	2.00	1.90	1.85	1.80	1.70	1.65	1.60	1.49
Noncurrent Deferred & Payable Income Tax Liabilities	77	63	62	59	51	50	50	45	48	48	53
Other Noncurrent Operating Liabilities	39	13	13	13	14	14	13	12	12	12	11
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	896	973	1,007	1,025	1,079	1,112	1,177	1,209	1,268	1,298	1,285
Total Preferred & Common Equity	896	973	1,007	1,025	1,079	1,112	1,177	1,209	1,268	1,298	1,285
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	896	973	1,007	1,025	1,079	1,112	1,177	1,209	1,268	1,298	1,285
Common Stock	127	134	139	143	156	161	170	176	154	143	92
Retained Earnings	816	837	867	896	926	959	992	1,035	1,073	1,113	1,162
Accumulated Other Comprehensive Income / (Loss)	-47	1.86	0.19	-14	-3.87	-7.13	15	-2.26	42	42	32

This table displays calculated financial ratios and metrics derived from Balchem's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.05%	0.13%	7.52%	8.22%	0.00%	9.31%	13.56%	17.94%	-2.11%	3.39%	8.75%
EBITDA Growth	18.60%	2.08%	2.94%	7.77%	-1.99%	9.33%	8.90%	10.93%	9.67%	7.52%	10.39%
EBIT Growth	14.02%	-3.69%	6.46%	11.06%	-3.94%	8.22%	15.18%	12.79%	11.01%	14.45%	14.36%
NOPAT Growth	14.44%	-4.88%	60.89%	-13.85%	-0.34%	4.37%	10.70%	16.90%	10.06%	12.15%	15.36%
Net Income Growth	13.05%	-6.28%	60.92%	-12.77%	1.40%	6.22%	13.57%	9.64%	3.01%	18.36%	20.53%
EPS Growth	11.83%	-7.41%	59.43%	-13.26%	1.24%	6.12%	13.08%	10.54%	3.08%	17.31%	20.87%
Operating Cash Flow Growth	21.65%	3.65%	2.79%	7.30%	4.86%	20.92%	6.66%	-13.69%	32.64%	-0.96%	18.99%
Free Cash Flow Firm Growth	112.33%	-145.99%	332.51%	27.46%	-160.41%	298.49%	30.86%	-362.06%	142.66%	-1.68%	-29.44%
Invested Capital Growth	0.43%	12.94%	4.21%	0.15%	16.58%	-1.27%	-3.58%	50.68%	-1.55%	-0.25%	4.54%
Revenue Q/Q Growth	-5.14%	1.47%	3.21%	0.67%	0.47%	2.06%	4.23%	2.10%	-0.41%	1.20%	2.33%
EBITDA Q/Q Growth	-3.62%	3.08%	0.88%	0.38%	-1.45%	3.75%	2.41%	-0.03%	2.81%	2.48%	2.19%
EBIT Q/Q Growth	-4.91%	2.74%	1.95%	0.55%	-3.18%	5.02%	3.94%	-1.16%	3.70%	5.02%	2.26%
NOPAT Q/Q Growth	-5.19%	0.46%	40.45%	-21.51%	-0.42%	1.52%	2.74%	1.72%	2.58%	3.75%	3.28%
Net Income Q/Q Growth	-5.33%	0.48%	40.69%	-21.59%	0.06%	2.15%	2.99%	-3.25%	5.07%	5.71%	3.78%
EPS Q/Q Growth	-5.03%	0.00%	40.20%	-21.94%	0.00%	2.36%	2.44%	-2.69%	5.02%	5.65%	3.94%
Operating Cash Flow Q/Q Growth	-9.68%	2.69%	3.14%	7.57%	-5.00%	11.06%	-2.11%	-2.01%	16.30%	-7.66%	7.42%
Free Cash Flow Firm Q/Q Growth	-21.32%	29.25%	-2.38%	15.64%	-635.29%	115.14%	11.53%	-20.73%	53.96%	9.34%	3.87%
Invested Capital Q/Q Growth	0.57%	-0.95%	2.84%	-1.46%	5.27%	-0.51%	-1.72%	3.43%	-0.23%	-0.76%	-0.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.43%	32.69%	31.78%	31.73%	32.84%	31.82%	30.43%	29.76%	32.75%	35.25%	35.74%
EBITDA Margin	24.18%	24.65%	23.60%	23.51%	23.04%	23.04%	22.10%	20.78%	23.29%	24.22%	24.58%
Operating Margin	17.01%	16.42%	16.29%	16.64%	15.93%	15.80%	15.96%	15.41%	17.26%	19.18%	20.18%
EBIT Margin	16.95%	16.30%	16.14%	16.57%	15.91%	15.75%	15.98%	15.28%	17.33%	19.19%	20.18%
Profit (Net Income) Margin	10.81%	10.12%	15.14%	12.21%	12.38%	12.03%	12.03%	11.18%	11.77%	13.47%	14.93%
Tax Burden Percent	68.60%	67.49%	101.79%	79.34%	82.58%	79.52%	76.74%	78.78%	79.08%	77.18%	77.80%
Interest Burden Percent	92.97%	91.95%	92.16%	92.86%	94.18%	96.00%	98.08%	92.87%	85.86%	90.97%	95.12%
Effective Tax Rate	31.40%	32.51%	-1.79%	20.66%	17.42%	20.48%	23.26%	21.22%	20.92%	22.82%	22.20%
Return on Invested Capital (ROIC)	9.33%	8.32%	12.36%	10.42%	9.58%	9.35%	10.61%	10.08%	9.30%	10.52%	11.88%
ROIC Less NNEP Spread (ROIC-NNEP)	7.53%	6.14%	8.62%	6.45%	6.56%	6.99%	8.11%	6.11%	4.45%	5.22%	7.08%
Return on Net Nonoperating Assets (RNNOA)	4.63%	3.05%	3.48%	1.59%	1.52%	1.42%	0.66%	1.53%	1.60%	1.14%	0.98%
Return on Equity (ROE)	13.96%	11.37%	15.83%	12.01%	11.10%	10.77%	11.27%	11.61%	10.90%	11.66%	12.86%
Cash Return on Invested Capital (CROIC)	8.90%	-3.84%	8.23%	10.28%	-5.73%	10.63%	14.25%	-30.36%	10.86%	10.77%	7.44%
Operating Return on Assets (OROA)	10.76%	9.87%	10.04%	10.97%	9.59%	9.55%	10.80%	10.20%	9.92%	11.54%	12.83%
Return on Assets (ROA)	6.86%	6.12%	9.42%	8.08%	7.46%	7.29%	8.13%	7.46%	6.74%	8.10%	9.50%
Return on Common Equity (ROCE)	13.96%	11.37%	15.83%	12.01%	11.10%	10.77%	11.27%	11.61%	10.90%	11.66%	12.86%
Return on Equity Simple (ROE_SIMPLE)	12.88%	10.74%	14.60%	11.36%	10.71%	10.22%	10.96%	11.23%	10.30%	11.17%	0.00%
Net Operating Profit after Tax (NOPAT)	64	61	99	85	85	88	98	114	126	141	163
NOPAT Margin	11.67%	11.08%	16.58%	13.20%	13.16%	12.56%	12.25%	12.14%	13.65%	14.80%	15.70%
Net Nonoperating Expense Percent (NNEP)	1.80%	2.18%	3.73%	3.97%	3.02%	2.36%	2.50%	3.96%	4.85%	5.30%	4.80%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	8.12%	9.11%	10.37%	11.27%
Cost of Revenue to Revenue	69.57%	67.31%	68.22%	68.27%	67.16%	68.18%	69.57%	70.24%	67.25%	64.75%	64.26%
SG&A Expenses to Revenue	12.34%	14.95%	13.92%	13.29%	15.14%	14.56%	12.78%	13.06%	13.86%	14.31%	13.77%
R&D to Revenue	1.08%	1.32%	1.56%	1.80%	1.77%	1.47%	1.69%	1.29%	1.63%	1.76%	1.78%
Operating Expenses to Revenue	13.42%	16.27%	15.49%	15.09%	16.90%	16.02%	14.48%	14.35%	15.49%	16.07%	15.55%
Earnings before Interest and Taxes (EBIT)	94	90	96	107	102	111	128	144	160	183	209
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	134	136	140	151	148	162	177	196	215	231	255
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.97	4.92	4.05	3.56	4.31	4.43	6.16	4.14	4.53	4.61	3.95
Price to Tangible Book Value (P/TBV)	0.00	0.00	52.68	18.35	42.30	20.73	20.89	0.00	56.89	25.87	17.88
Price to Revenue (P/Rev)	3.33	4.64	4.20	3.83	4.98	5.22	6.76	4.12	5.17	5.56	4.79
Price to Earnings (P/E)	30.79	45.84	27.75	31.35	40.21	43.39	56.17	36.85	43.95	41.24	32.08
Dividend Yield	0.58%	0.47%	0.54%	0.62%	0.52%	0.51%	0.38%	0.59%	0.53%	0.53%	0.00%
Earnings Yield	3.25%	2.18%	3.60%	3.19%	2.49%	2.30%	1.78%	2.71%	2.28%	2.42%	3.12%
Enterprise Value to Invested Capital (EV/IC)	2.97	3.60	3.29	3.15	3.57	4.01	5.97	3.14	3.75	4.07	3.63
Enterprise Value to Revenue (EV/Rev)	3.72	5.09	4.51	4.00	5.27	5.35	6.77	4.55	5.46	5.73	4.90
Enterprise Value to EBITDA (EV/EBITDA)	15.39	20.64	19.12	17.00	22.89	23.21	30.62	21.88	23.44	23.64	19.92
Enterprise Value to EBIT (EV/EBIT)	21.96	31.21	27.95	24.12	33.14	33.95	42.34	29.76	31.49	29.84	24.27
Enterprise Value to NOPAT (EV/NOPAT)	31.91	45.91	27.21	30.27	40.08	42.58	55.25	37.47	39.99	38.68	31.19
Enterprise Value to Operating Cash Flow (EV/OCF)	19.81	26.16	24.26	21.67	27.27	25.01	33.68	30.94	27.40	30.00	23.45
Enterprise Value to Free Cash Flow (EV/FCFF)	33.45	0.00	40.82	30.70	0.00	37.46	41.12	0.00	34.25	37.78	49.81
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.55	0.36	0.24	0.34	0.21	0.13	0.50	0.31	0.18	0.15
Long-Term Debt to Equity	0.58	0.48	0.31	0.24	0.34	0.21	0.13	0.50	0.31	0.18	0.15
Financial Leverage	0.61	0.50	0.40	0.25	0.23	0.20	0.08	0.25	0.36	0.22	0.14
Leverage Ratio	2.04	1.86	1.68	1.49	1.49	1.48	1.39	1.56	1.62	1.44	1.35
Compound Leverage Factor	1.89	1.71	1.55	1.38	1.40	1.42	1.36	1.44	1.39	1.31	1.29
Debt to Total Capital	39.49%	35.55%	26.71%	19.11%	25.64%	17.57%	11.22%	33.35%	23.74%	15.51%	12.95%
Short-Term Debt to Total Capital	4.57%	4.33%	4.16%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	34.92%	31.22%	22.55%	19.11%	25.64%	17.57%	11.22%	33.35%	23.74%	15.51%	12.95%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.51%	64.45%	73.29%	80.89%	74.36%	82.43%	88.78%	66.65%	76.26%	84.49%	87.05%
Debt to EBITDA	2.27	2.11	1.60	1.08	1.73	1.09	0.63	2.40	1.53	0.91	0.73
Net Debt to EBITDA	1.63	1.82	1.31	0.72	1.29	0.57	0.04	2.06	1.23	0.70	0.44
Long-Term Debt to EBITDA	2.00	1.85	1.35	1.08	1.73	1.09	0.63	2.40	1.53	0.91	0.73
Debt to NOPAT	4.70	4.69	2.28	1.92	3.03	2.00	1.13	4.11	2.61	1.50	1.15
Net Debt to NOPAT	3.38	4.06	1.87	1.28	2.25	1.04	0.08	3.52	2.09	1.14	0.69
Long-Term Debt to NOPAT	4.15	4.12	1.92	1.92	3.03	2.00	1.13	4.11	2.61	1.50	1.15
Altman Z-Score	4.34	5.18	6.06	7.05	6.40	8.41	12.10	5.11	7.09	9.47	9.04
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.44	1.87	1.84	2.76	2.76	2.83	2.24	2.40	2.12	1.99	2.07
Quick Ratio	1.79	1.21	1.21	1.87	1.72	1.94	1.53	1.41	1.28	1.07	1.24
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	61	-28	66	84	-51	100	131	-345	147	145	102
Operating Cash Flow to CapEx	251.60%	467.27%	393.73%	632.81%	736.89%	446.03%	433.29%	278.53%	510.29%	515.55%	501.11%
Free Cash Flow to Firm to Interest Expense	9.32	-3.90	8.73	11.01	-8.49	22.63	53.53	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	15.75	14.83	14.69	15.60	20.89	33.90	65.36	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	9.49	11.66	10.96	13.13	18.05	26.30	50.27	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.63	0.61	0.62	0.66	0.60	0.61	0.68	0.67	0.57	0.60	0.64
Accounts Receivable Turnover	8.34	7.70	6.82	6.75	6.67	7.34	7.41	7.57	7.18	7.79	7.88
Inventory Turnover	8.03	7.21	6.88	6.87	5.72	6.21	6.88	6.28	5.41	5.14	5.08
Fixed Asset Turnover	3.81	3.41	3.35	3.38	3.16	3.16	3.43	3.70	3.37	3.42	3.52
Accounts Payable Turnover	19.68	15.77	13.31	14.22	12.25	15.73	13.90	11.66	11.00	11.20	11.57
Days Sales Outstanding (DSO)	43.76	47.42	53.54	54.09	54.72	49.71	49.25	48.22	50.82	46.87	46.32
Days Inventory Outstanding (DIO)	45.44	50.65	53.04	53.11	63.77	58.78	53.08	58.10	67.42	71.03	71.81
Days Payable Outstanding (DPO)	18.54	23.15	27.42	25.66	29.81	23.21	26.26	31.31	33.19	32.58	31.53
Cash Conversion Cycle (CCC)	70.65	74.92	79.16	81.54	88.68	85.28	76.07	75.01	85.05	85.32	86.60
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	692	782	815	816	951	939	906	1,364	1,343	1,340	1,401
Invested Capital Turnover	0.80	0.75	0.75	0.79	0.73	0.74	0.87	0.83	0.68	0.71	0.76
Increase / (Decrease) in Invested Capital	2.97	90	33	1.18	135	-12	-34	459	-21	-3.35	61
Enterprise Value (EV)	2,057	2,815	2,684	2,572	3,394	3,763	5,406	4,286	5,035	5,460	5,079
Market Capitalization	1,839	2,566	2,499	2,463	3,204	3,671	5,399	3,883	4,771	5,299	4,967
Book Value per Share	$14.71	$16.43	$19.28	$21.45	$23.12	$25.60	$27.08	$29.20	$32.69	$35.37	$38.83
Tangible Book Value per Share	($1.75)	($2.09)	$1.48	$4.16	$2.35	$5.47	$7.98	($1.39)	$2.60	$6.30	$8.58
Total Capital	766	808	842	855	1,000	1,005	988	1,408	1,382	1,361	1,444
Total Debt	303	287	225	163	256	177	111	470	328	211	187
Total Long-Term Debt	268	252	190	163	256	177	111	470	328	211	187
Net Debt	218	249	184	109	191	92	7.63	403	264	162	112
Capital Expenditures (CapEx)	41	23	28	19	17	34	37	50	36	35	43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	67	84	86	90	97	88	75	129	101	107	115
Debt-free Net Working Capital (DFNWC)	152	122	126	144	163	172	178	196	166	156	189
Net Working Capital (NWC)	117	87	91	144	163	172	178	196	166	156	189
Net Nonoperating Expense (NNE)	4.73	5.33	8.57	6.40	5.02	3.76	1.74	9.01	17	13	8.01
Net Nonoperating Obligations (NNO)	229	261	198	124	208	111	29	426	289	190	143
Total Depreciation and Amortization (D&A)	40	46	44	45	46	51	49	52	55	48	46
Debt-free, Cash-free Net Working Capital to Revenue	12.20%	15.15%	14.38%	13.98%	15.07%	12.49%	9.41%	13.71%	10.98%	11.17%	11.06%
Debt-free Net Working Capital to Revenue	27.54%	22.13%	21.17%	22.41%	25.27%	24.51%	22.33%	20.77%	17.97%	16.37%	18.25%
Net Working Capital to Revenue	21.21%	15.81%	15.29%	22.41%	25.27%	24.51%	22.33%	20.77%	17.97%	16.37%	18.25%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.92	$1.78	$2.83	$2.45	$2.48	$2.63	$2.98	$3.29	$3.38	$3.97	$4.80
Adjusted Weighted Average Basic Shares Outstanding	31.54M	31.77M	32.04M	32.27M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M	32.03M
Adjusted Diluted Earnings per Share	$1.89	$1.75	$2.79	$2.42	$2.45	$2.60	$2.94	$3.25	$3.35	$3.93	$4.75
Adjusted Weighted Average Diluted Shares Outstanding	31.54M	31.77M	32.04M	32.27M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M	32.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.54M	31.77M	32.04M	32.27M	32.25M	32.39M	32.19M	32.17M	32.27M	32.53M	32.03M
Normalized Net Operating Profit after Tax (NOPAT)	64	61	68	85	85	88	98	114	126	141	163
Normalized NOPAT Margin	11.67%	11.08%	11.40%	13.20%	13.16%	12.56%	12.25%	12.14%	13.65%	14.80%	15.70%
Pre Tax Income Margin	15.76%	14.99%	14.88%	15.39%	14.99%	15.12%	15.67%	14.19%	14.88%	17.45%	19.19%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.20	12.43	12.75	14.01	17.19	24.97	51.99	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	9.78	8.45	13.10	11.16	14.21	19.91	39.84	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	7.94	9.26	9.02	11.55	14.36	17.37	36.91	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	3.52	5.28	9.37	8.70	11.38	12.31	24.76	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	15.49%	19.15%	13.40%	17.09%	19.00%	19.74%	19.48%	19.66%	21.07%	19.91%	18.27%
Augmented Payout Ratio	17.51%	21.99%	15.51%	18.87%	45.76%	35.65%	56.15%	53.28%	25.19%	24.33%	87.78%

This table displays calculated financial ratios and metrics derived from Balchem's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	32,025,392.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	32,025,392.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.26
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.86%	-1.65%	3.06%	1.22%	4.35%	4.94%	4.53%	9.14%	11.51%	9.84%	8.06%
EBITDA Growth	16.49%	11.48%	15.70%	1.72%	3.51%	10.61%	10.66%	8.98%	12.50%	9.38%	8.64%
EBIT Growth	24.02%	15.77%	21.81%	4.37%	11.37%	22.68%	20.39%	13.88%	13.99%	9.79%	7.61%
NOPAT Growth	27.29%	11.02%	22.16%	6.06%	6.42%	16.64%	20.28%	12.78%	14.20%	14.45%	8.21%
Net Income Growth	15.15%	24.49%	27.64%	6.51%	16.38%	26.02%	27.83%	19.36%	19.07%	16.80%	8.72%
EPS Growth	15.38%	24.24%	27.14%	5.38%	14.44%	25.61%	26.97%	19.39%	20.39%	17.48%	10.62%
Operating Cash Flow Growth	11.79%	61.82%	-4.16%	28.58%	10.27%	-22.39%	9.19%	5.02%	27.82%	28.59%	9.89%
Free Cash Flow Firm Growth	102.03%	112.01%	117.72%	221.14%	340.29%	-24.40%	-88.74%	-162.55%	-152.14%	-150.78%	10.10%
Invested Capital Growth	2.07%	-1.55%	-2.70%	-2.12%	0.29%	-0.25%	2.36%	6.04%	4.41%	4.54%	2.48%
Revenue Q/Q Growth	-0.56%	-0.54%	4.79%	-2.33%	2.50%	0.03%	4.38%	1.98%	4.73%	-1.47%	2.69%
EBITDA Q/Q Growth	-0.21%	-7.49%	6.27%	3.68%	1.54%	-1.13%	6.32%	2.10%	4.82%	-3.88%	5.61%
EBIT Q/Q Growth	-1.13%	-10.47%	9.57%	7.62%	5.49%	-1.38%	7.53%	1.80%	5.59%	-5.01%	5.39%
NOPAT Q/Q Growth	3.51%	-11.67%	6.76%	8.67%	3.85%	-3.19%	10.08%	1.89%	5.16%	-2.98%	4.08%
Net Income Q/Q Growth	-3.44%	-8.35%	8.77%	10.64%	5.51%	-0.75%	10.33%	3.31%	5.25%	-2.64%	2.70%
EPS Q/Q Growth	-3.23%	-8.89%	8.54%	10.11%	5.10%	0.00%	9.71%	3.54%	5.98%	-2.42%	3.31%
Operating Cash Flow Q/Q Growth	32.97%	44.88%	-50.47%	34.76%	14.02%	1.98%	-30.32%	29.61%	38.77%	2.60%	-40.45%
Free Cash Flow Firm Q/Q Growth	114.12%	589.14%	35.08%	-7.81%	-48.70%	18.32%	-79.88%	-612.10%	57.24%	-15.24%	143.63%
Invested Capital Q/Q Growth	-1.23%	-0.23%	-0.32%	-0.35%	1.20%	-0.76%	2.28%	3.23%	-0.36%	-0.63%	0.26%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	33.29%	32.79%	34.01%	35.46%	35.58%	35.97%	35.19%	36.45%	35.68%	35.62%	37.34%
EBITDA Margin	24.73%	23.01%	23.33%	24.77%	24.53%	24.25%	24.70%	24.73%	24.75%	24.15%	24.83%
Operating Margin	18.97%	16.76%	17.39%	19.56%	20.00%	19.77%	20.36%	20.14%	20.40%	19.84%	20.55%
EBIT Margin	18.73%	16.86%	17.63%	19.42%	19.99%	19.71%	20.30%	20.27%	20.43%	19.70%	20.22%
Profit (Net Income) Margin	12.64%	11.65%	12.09%	13.70%	14.10%	13.99%	14.79%	14.98%	15.06%	14.88%	14.88%
Tax Burden Percent	79.71%	80.10%	78.66%	77.79%	77.09%	75.49%	77.29%	78.10%	77.41%	78.40%	76.70%
Interest Burden Percent	84.69%	86.28%	87.22%	90.67%	91.51%	94.04%	94.25%	94.66%	95.19%	96.34%	95.96%
Effective Tax Rate	20.29%	19.90%	21.34%	22.21%	22.91%	24.51%	22.71%	21.90%	22.59%	21.60%	23.30%
Return on Invested Capital (ROIC)	10.51%	9.15%	9.37%	10.52%	10.78%	10.61%	11.21%	11.28%	11.60%	11.77%	12.01%
ROIC Less NNEP Spread (ROIC-NNEP)	8.98%	8.01%	8.22%	9.29%	9.50%	9.68%	10.08%	10.25%	10.22%	10.71%	10.32%
Return on Net Nonoperating Assets (RNNOA)	3.48%	2.88%	2.66%	2.54%	2.13%	2.10%	1.86%	1.59%	1.18%	1.48%	1.16%
Return on Equity (ROE)	13.99%	12.03%	12.02%	13.06%	12.91%	12.71%	13.07%	12.87%	12.77%	13.25%	13.17%
Cash Return on Invested Capital (CROIC)	7.16%	10.86%	12.45%	12.07%	9.80%	10.77%	8.58%	5.23%	7.11%	7.44%	9.52%
Operating Return on Assets (OROA)	10.72%	9.65%	10.19%	11.34%	11.77%	11.85%	12.22%	12.28%	12.71%	12.53%	12.91%
Return on Assets (ROA)	7.24%	6.67%	6.99%	8.00%	8.30%	8.41%	8.90%	9.08%	9.37%	9.46%	9.50%
Return on Common Equity (ROCE)	13.99%	12.03%	12.02%	13.06%	12.91%	12.71%	13.07%	12.87%	12.77%	13.25%	13.17%
Return on Equity Simple (ROE_SIMPLE)	10.08%	0.00%	10.64%	10.50%	10.32%	0.00%	11.30%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	35	31	33	36	37	36	39	40	42	41	43
NOPAT Margin	15.12%	13.43%	13.68%	15.22%	15.42%	14.92%	15.74%	15.73%	15.79%	15.55%	15.76%
Net Nonoperating Expense Percent (NNEP)	1.53%	1.13%	1.15%	1.23%	1.28%	0.93%	1.13%	1.03%	1.38%	1.06%	1.69%
Return On Investment Capital (ROIC_SIMPLE)	-	2.22%	-	-	-	2.63%	2.78%	2.71%	2.86%	2.84%	2.89%
Cost of Revenue to Revenue	66.71%	67.21%	65.99%	64.54%	64.42%	64.03%	64.81%	63.55%	64.32%	64.38%	62.66%
SG&A Expenses to Revenue	12.64%	14.31%	14.91%	14.24%	13.77%	14.33%	12.97%	14.63%	13.60%	13.87%	14.62%
R&D to Revenue	1.68%	1.72%	1.71%	1.65%	1.80%	1.88%	1.86%	1.68%	1.68%	1.92%	2.17%
Operating Expenses to Revenue	14.32%	16.03%	16.62%	15.89%	15.57%	16.21%	14.83%	16.31%	15.28%	15.78%	16.79%
Earnings before Interest and Taxes (EBIT)	43	39	42	45	48	47	51	52	55	52	55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	57	53	56	58	59	58	62	63	66	64	67
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.88	4.53	4.63	4.49	4.85	4.61	4.47	4.10	3.75	3.95	4.22
Price to Tangible Book Value (P/TBV)	59.76	56.89	39.90	30.03	26.12	25.87	21.63	18.57	15.51	17.88	17.11
Price to Revenue (P/Rev)	4.29	5.17	5.37	5.35	6.06	5.56	5.60	5.27	4.81	4.79	5.13
Price to Earnings (P/E)	38.50	43.95	43.51	42.74	46.98	41.24	39.55	36.38	32.64	32.08	34.34
Dividend Yield	0.58%	0.53%	0.51%	0.51%	0.45%	0.53%	0.52%	0.55%	0.58%	0.00%	0.57%
Earnings Yield	2.60%	2.28%	2.30%	2.34%	2.13%	2.42%	2.53%	2.75%	3.06%	3.12%	2.91%
Enterprise Value to Invested Capital (EV/IC)	3.19	3.75	3.93	3.91	4.36	4.07	4.06	3.77	3.53	3.63	3.95
Enterprise Value to Revenue (EV/Rev)	4.64	5.46	5.65	5.59	6.24	5.73	5.77	5.42	4.92	4.90	5.25
Enterprise Value to EBITDA (EV/EBITDA)	20.57	23.44	23.63	23.34	26.10	23.64	23.48	22.05	19.97	19.92	21.31
Enterprise Value to EBIT (EV/EBIT)	27.88	31.49	31.39	30.79	33.77	29.84	29.03	26.98	24.35	24.27	26.03
Enterprise Value to NOPAT (EV/NOPAT)	35.03	39.99	39.87	38.95	43.23	38.68	37.62	35.03	31.59	31.19	33.40
Enterprise Value to Operating Cash Flow (EV/OCF)	27.20	27.40	28.83	27.11	29.85	30.00	30.05	28.50	24.71	23.45	25.20
Enterprise Value to Free Cash Flow (EV/FCFF)	45.02	34.25	31.10	32.03	44.51	37.78	47.82	74.27	50.75	49.81	41.99
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.39	0.31	0.30	0.26	0.21	0.18	0.18	0.17	0.14	0.15	0.15
Long-Term Debt to Equity	0.39	0.31	0.30	0.26	0.21	0.18	0.18	0.17	0.14	0.15	0.15
Financial Leverage	0.39	0.36	0.32	0.27	0.22	0.22	0.18	0.16	0.12	0.14	0.11
Leverage Ratio	1.68	1.62	1.57	1.51	1.45	1.44	1.40	1.37	1.32	1.35	1.33
Compound Leverage Factor	1.43	1.40	1.37	1.37	1.33	1.35	1.32	1.29	1.25	1.31	1.27
Debt to Total Capital	27.96%	23.74%	22.90%	20.43%	17.33%	15.51%	14.90%	14.34%	12.00%	12.95%	13.01%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	27.96%	23.74%	22.90%	20.43%	17.33%	15.51%	14.90%	14.34%	12.00%	12.95%	13.01%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	72.04%	76.26%	77.10%	79.57%	82.67%	84.49%	85.10%	85.66%	88.00%	87.05%	86.99%
Debt to EBITDA	1.90	1.53	1.44	1.28	1.09	0.91	0.89	0.88	0.71	0.73	0.74
Net Debt to EBITDA	1.54	1.23	1.17	0.99	0.77	0.70	0.68	0.61	0.45	0.44	0.46
Long-Term Debt to EBITDA	1.90	1.53	1.44	1.28	1.09	0.91	0.89	0.88	0.71	0.73	0.74
Debt to NOPAT	3.24	2.61	2.43	2.13	1.81	1.50	1.43	1.39	1.12	1.15	1.16
Net Debt to NOPAT	2.62	2.09	1.97	1.66	1.27	1.14	1.09	0.96	0.71	0.69	0.72
Long-Term Debt to NOPAT	3.24	2.61	2.43	2.13	1.81	1.50	1.43	1.39	1.12	1.15	1.16
Altman Z-Score	5.75	6.84	7.52	8.17	9.88	9.18	9.67	9.34	9.86	8.73	9.83
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.16	2.12	2.61	2.83	2.98	1.99	2.44	2.64	2.72	2.07	2.55
Quick Ratio	1.91	1.28	1.61	1.65	1.77	1.07	1.29	1.46	1.56	1.24	1.49
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	7.52	52	70	65	33	39	7.88	-40	-17	-20	8.68
Operating Cash Flow to CapEx	560.76%	575.38%	483.18%	654.14%	560.80%	411.14%	655.82%	721.85%	439.99%	415.10%	640.98%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	12.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	6.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	4.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.57	0.57	0.58	0.58	0.59	0.60	0.60	0.61	0.62	0.64	0.64
Accounts Receivable Turnover	6.87	7.18	6.85	7.50	7.55	7.79	7.14	7.60	8.04	7.88	7.43
Inventory Turnover	4.93	5.41	5.27	5.09	5.26	5.14	4.87	4.77	5.18	5.08	4.62
Fixed Asset Turnover	3.50	3.37	3.38	3.43	3.45	3.42	3.46	3.50	3.52	3.52	3.60
Accounts Payable Turnover	10.27	11.00	10.94	11.12	12.84	11.20	9.89	10.35	13.92	11.57	9.86
Days Sales Outstanding (DSO)	53.16	50.82	53.25	48.64	48.33	46.87	51.15	48.01	45.39	46.32	49.14
Days Inventory Outstanding (DIO)	74.04	67.42	69.31	71.67	69.41	71.03	74.95	76.48	70.41	71.81	79.00
Days Payable Outstanding (DPO)	35.55	33.19	33.37	32.82	28.42	32.58	36.92	35.28	26.22	31.53	37.03
Cash Conversion Cycle (CCC)	91.65	85.05	89.19	87.50	89.32	85.32	89.17	89.21	89.58	86.60	91.11
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,346	1,343	1,339	1,334	1,350	1,340	1,371	1,415	1,410	1,401	1,405
Invested Capital Turnover	0.70	0.68	0.68	0.69	0.70	0.71	0.71	0.72	0.73	0.76	0.76
Increase / (Decrease) in Invested Capital	27	-21	-37	-29	3.89	-3.35	32	81	60	61	34
Enterprise Value (EV)	4,298	5,035	5,256	5,214	5,883	5,460	5,562	5,340	4,982	5,079	5,547
Market Capitalization	3,977	4,771	4,996	4,992	5,710	5,299	5,400	5,193	4,870	4,967	5,428
Book Value per Share	$31.80	$32.69	$33.27	$34.31	$36.29	$35.37	$37.15	$38.87	$39.99	$38.83	$40.13
Tangible Book Value per Share	$2.06	$2.60	$3.86	$5.13	$6.74	$6.30	$7.67	$8.57	$9.67	$8.58	$9.90
Total Capital	1,423	1,382	1,399	1,398	1,424	1,361	1,420	1,480	1,475	1,444	1,477
Total Debt	398	328	321	286	247	211	212	212	177	187	192
Total Long-Term Debt	398	328	321	286	247	211	212	212	177	187	192
Net Debt	321	264	260	222	173	162	162	147	112	112	119
Capital Expenditures (CapEx)	8.30	12	6.91	6.88	9.15	13	5.56	6.55	15	16	6.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	156	101	140	143	143	107	151	161	152	115	164
Debt-free Net Working Capital (DFNWC)	233	166	200	207	217	156	201	227	217	189	236
Net Working Capital (NWC)	233	166	200	207	217	156	201	227	217	189	236
Net Nonoperating Expense (NNE)	5.69	4.06	3.80	3.56	3.16	2.23	2.38	1.90	1.96	1.77	2.38
Net Nonoperating Obligations (NNO)	321	289	260	222	173	190	162	147	112	143	119
Total Depreciation and Amortization (D&A)	14	14	14	13	11	11	11	11	12	12	12
Debt-free, Cash-free Net Working Capital to Revenue	16.87%	10.98%	15.07%	15.35%	15.16%	11.17%	15.63%	16.36%	15.02%	11.06%	15.47%
Debt-free Net Working Capital to Revenue	25.17%	17.97%	21.56%	22.18%	22.98%	16.37%	20.81%	23.00%	21.44%	18.25%	22.36%
Net Working Capital to Revenue	25.17%	17.97%	21.56%	22.18%	22.98%	16.37%	20.81%	23.00%	21.44%	18.25%	22.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.91	$0.82	$0.90	$0.99	$1.05	$1.03	$1.14	$1.18	$1.25	$1.23	$1.26
Adjusted Weighted Average Basic Shares Outstanding	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M	32.62M	32.46M	32.39M	32.03M	32.13M
Adjusted Diluted Earnings per Share	$0.90	$0.82	$0.89	$0.98	$1.03	$1.03	$1.13	$1.17	$1.24	$1.21	$1.25
Adjusted Weighted Average Diluted Shares Outstanding	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M	32.62M	32.46M	32.39M	32.03M	32.13M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.24M	32.27M	32.42M	32.44M	32.51M	32.53M	32.62M	32.46M	32.39M	32.03M	32.13M
Normalized Net Operating Profit after Tax (NOPAT)	35	31	33	36	37	36	39	40	42	41	43
Normalized NOPAT Margin	15.12%	13.43%	13.68%	15.22%	15.42%	14.92%	15.74%	15.73%	15.79%	15.55%	15.76%
Pre Tax Income Margin	15.86%	14.55%	15.38%	17.61%	18.29%	18.53%	19.14%	19.18%	19.45%	18.98%	19.40%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	7.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	6.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	6.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	4.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	22.15%	21.07%	22.26%	21.90%	21.04%	19.91%	20.71%	19.81%	18.95%	18.27%	19.48%
Augmented Payout Ratio	26.21%	25.19%	27.33%	26.83%	25.83%	24.33%	24.97%	47.17%	55.36%	87.78%	94.13%

Financials Breakdown Chart

Key Financial Trends

Here is a concise five-year to four-year trend snapshot for Balchem Corp (BCPC) based on the quarterly statements provided. The focus is on what may matter most to a retail investor looking for growth, profitability, and financial strength over time.

Revenue growth: Q4 2025 Operating Revenue of 263,617,000, up from 232,531,000 in Q4 2022 (about +13% over the period).
Gross margin expansion: 2024–2025 gross margin around 35.5%–36% vs roughly 29.5% in Q4 2022, indicating improving profitability on product sales.
Net income growth: Net income (consolidated) rose from about 21,406,000 in Q4 2022 to 39,225,000 in Q4 2025.
Earnings per share growth: Basic EPS increased from about 0.67 in Q4 2022 to 1.23 in Q4 2025.
Operating cash flow strength: Net cash from continuing operating activities was 67,275,000 in Q4 2025 (consistent strength across 2025 quarters).
Free cash flow generation: Approximately 51.1 million in Q4 2025 (CFO 67.3m minus capex 16.2m), signaling solid cash generation after maintenance capex.

Liquidity snapshot: Cash & equivalents have been in the mid- to high-60 million range in 2025 (example: Q3 2025 65.093 million; Q2 2025 65.427 million), suggesting modest liquidity but not excessive cash on hand.
Asset mix stability: Total assets sit around 1.66–1.68 billion in 2025, with goodwill around 770–816 million and intangible assets in the low-to-mid hundreds of millions, a stable but asset-heavy balance sheet.

Share repurchases pressure on liquidity: In 2025 Balchem pursued sizable share buybacks (Q4 2025 repurchase around 53.6 million; earlier quarters also sizable), which reduces cash and could constrain liquidity if cash generation slows.
High goodwill balance and impairment risk: Goodwill remains large (around 770–816 million across 2024–2025), introducing potential impairment risk in a downturn or if market conditions deteriorate.

05/21/26 09:24 PM ETAI Generated. May Contain Errors.

Balchem Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Balchem's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Balchem's net income appears to be on an upward trend, with a most recent value of $154.85 million in 2025, rising from $59.72 million in 2015. The previous period was $128.48 million in 2024. See where experts think Balchem is headed by visiting Balchem's forecast page.

Balchem's total operating income in 2025 was $209.33 million, based on the following breakdown:

Total Gross Profit: $370.63 million
Total Operating Expenses: $161.31 million

Over the last 10 years, Balchem's total revenue changed from $552.49 million in 2015 to $1.04 billion in 2025, a change of 87.7%.

Balchem's total liabilities were at $428.84 million at the end of 2025, a 0.8% increase from 2024, and a 3.1% increase since 2015.

In the past 10 years, Balchem's cash and equivalents has ranged from $38.64 million in 2016 to $103.24 million in 2021, and is currently $74.57 million as of their latest financial filing in 2025.

Over the last 10 years, Balchem's book value per share changed from 14.71 in 2015 to 38.83 in 2025, a change of 163.9%.

Related Companies

Financial statements for NASDAQ:BCPC last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Balchem (BCPC) Financials

Financials Breakdown Chart

Key Financial Trends

Balchem Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Balchem (BCPC) Financials

Annual Income Statements for Balchem

Quarterly Income Statements for Balchem

Annual Cash Flow Statements for Balchem

Quarterly Cash Flow Statements for Balchem

Annual Balance Sheets for Balchem

Quarterly Balance Sheets for Balchem

Annual Metrics And Ratios for Balchem

Quarterly Metrics And Ratios for Balchem

Financials Breakdown Chart

Key Financial Trends

Balchem Financials - Frequently Asked Questions

When does Balchem's financial year end?

How has Balchem's net income changed over the last 10 years?

What is Balchem's operating income?

How has Balchem's revenue changed over the last 10 years?

How much debt does Balchem have?

How much cash does Balchem have?

How has Balchem's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools